Facilitated By

San Antonio Medical Foundation

News

  • Seagen, Union Pacific rise; Range Resources, Tegna fall - MySA

    Pfizer is reportedly considering buying the biotechnology company. ... Japan-based Round1 bowling venue opening in San Antonio.

  • CSL's Phase 3 Study Shows First-In-Class Garadacimab Provides Patients with Significant ...

    KING OF PRUSSIA, PA — Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) ... (AAAAI) Annual Meeting, February 24-27, in San Antonio, Texas.

  • Escient Pharmaceuticals Announces Oral Presentation of Data Highlighting the Preclinical ...

    ... program at the American Academy of Allergy, Asthma and Immunology Annual meeting being held in San Antonio, TX, February 24-27, 2023.

  • CSL's Phase 3 Study Shows First-In-Class Garadacimab Provides Patients with ... - Yahoo Finance

    Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today presented results ... (AAAAI) Annual Meeting, February 24-27, in San Antonio, Texas.

  • CSL's Phase 3 Study Shows Firs - GuruFocus.com

    26, 2023 /PRNewswire/ -- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) ... (AAAAI) Annual Meeting, February 24-27, in San Antonio, Texas.